Cargando…

Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities

Progressive myoclonus epilepsies (PMEs) are a group of genetic neurological disorders characterised by the occurrence of epileptic seizures, myoclonus and progressive neurological deterioration including cerebellar involvement and dementia. The primary cause of PMEs is variable and alterations in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanz, Pascual, Serratosa, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520540/ https://www.ncbi.nlm.nih.gov/pubmed/32938505 http://dx.doi.org/10.1017/erm.2020.5

Ejemplares similares

Altered Expression of Peroxiredoxins in Mouse Model of Progressive Myoclonus Epilepsy upon LPS-Induced Neuroinflammation
por: Trstenjak Prebanda, Mojca, et al.
Publicado: (2021)

Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism
por: Couarch, Philippe, et al.
Publicado: (2011)

Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease
por: Sanz, Pascual, et al.
Publicado: (2021)

Progressive myoclonus epilepsy associated with SACS gene mutations
por: Nascimento, Fábio A., et al.
Publicado: (2016)

Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
por: Martin, Sarah, et al.
Publicado: (2019)

Juvenile Huntington’s disease masquerading as progressive myoclonus epilepsy
por: Thakor, Bina, et al.
Publicado: (2021)

Perampanel improved intractable myoclonus in two patients with myoclonus epilepsy
por: Iijima, Mutsumi, et al.
Publicado: (2019)

Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
por: Mitra, Sharmistha, et al.
Publicado: (2023)

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
por: Araújo, Bruna, et al.
Publicado: (2022)

Unmasking of myoclonus by lacosamide in generalized epilepsy
por: Birnbaum, Daniel, et al.
Publicado: (2016)

Novel Genetic and Phenotypic Expansion in GOSR2-Related Progressive Myoclonus Epilepsy
por: Hentrich, Lea, et al.
Publicado: (2023)

Progressive myoclonus epilepsy KCNC1 variant causes a developmental dendritopathy
por: Carpenter, Jenna C., et al.
Publicado: (2021)

Zonisamide‐responsive myoclonus in SEMA6B‐associated progressive myoclonic epilepsy
por: Herzog, Rebecca, et al.
Publicado: (2021)

Climate change and epilepsy: Insights from clinical and basic science studies
por: Gulcebi, Medine I., et al.
Publicado: (2021)

Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
por: Sharma, Rishabh, et al.
Publicado: (2019)

A Novel Mutation in KCDT7 Gene in an Indian Girl With Progressive Myoclonus Epilepsy
por: Dudipala, Sai Chandar, et al.
Publicado: (2021)

Late-onset Juvenile Myoclonic Epilepsy or Frontal Lobe Epilepsy with Myoclonus
por: Zhang, Xin-Yue, et al.
Publicado: (2016)

Case Report: Distinctive EEG Patterns in SCARB-2 Related Progressive Myoclonus Epilepsy
por: Hotait, Mostafa, et al.
Publicado: (2020)

Impaired osteoclast homeostasis in the cystatin B-deficient mouse model of progressive myoclonus epilepsy
por: Manninen, Otto, et al.
Publicado: (2015)

Progressive Myoclonus Epilepsies: Diagnostic Yield With Next-Generation Sequencing in Previously Unsolved Cases
por: Canafoglia, Laura, et al.
Publicado: (2021)

Brain inflammation is accompanied by peripheral inflammation in Cstb(−/−) mice, a model for progressive myoclonus epilepsy
por: Okuneva, Olesya, et al.
Publicado: (2016)

The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities
por: Werner, Haim
Publicado: (2023)

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
por: Gao, Chao, et al.
Publicado: (2023)

Role of genetic modifiers in Lafora progressive myoclonus epilepsy-a neurodegenerative disorder with defects in carbohydrate metabolism
por: Singh, Shweta, et al.
Publicado: (2012)

Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes
por: Castellotti, Barbara, et al.
Publicado: (2023)

NUS1 and Epilepsy-myoclonus-ataxia Syndrome: An Under-recognized Entity?
por: Riboldi, Giulietta M., et al.
Publicado: (2022)

Cell Secretome: Basic Insights and Therapeutic Opportunities for CNS Disorders
por: Pinho, Andreia G., et al.
Publicado: (2020)

The Interconnected Mechanisms of Oxidative Stress and Neuroinflammation in Epilepsy
por: Parsons, Anna L. M., et al.
Publicado: (2022)

Functional assays for the assessment of the pathogenicity of variants of GOSR2, an ER-to-Golgi SNARE involved in progressive myoclonus epilepsies
por: Völker, Jörn M., et al.
Publicado: (2017)

The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
por: van Egmond, Martje E., et al.
Publicado: (2017)

Variants in ATP6V0A1 cause progressive myoclonus epilepsy and developmental and epileptic encephalopathy
por: Bott, Laura C, et al.
Publicado: (2021)

A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon
por: Degeneffe, Aurélie, et al.
Publicado: (2018)

Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models
por: Sánchez, Marina P., et al.
Publicado: (2018)

Neuroinflammation: A Signature or a Cause of Epilepsy?
por: Pracucci, Enrico, et al.
Publicado: (2021)

Myoclonus- A Review
por: Chandarana, Mitesh, et al.
Publicado: (2021)

Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
por: Lehmann, Leanne, et al.
Publicado: (2021)

Basic Mechanisms of the Epilepsies
Publicado: (1971)

Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation
por: Madireddy, Sahithi, et al.
Publicado: (2023)

Network science for the identification of novel therapeutic targets in epilepsy
por: Scott, Rod C.
Publicado: (2016)

Familial Adult Myoclonus Epilepsy: A Non-Coding Repeat Expansion Disorder of Cerebellar–Thalamic–Cortical Loop
por: Cuccurullo, Claudia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8e2ooup6icg9kh403dkc81bbla